Predictors of the intima-media thickness of carotid artery in asymptomatic newly detected severe hypercholesterolemic patients

Clinical Physiology and Functional Imaging

Volumn 30, Issue 4, 2010, Pages 250-259

  Vladimirova Kitova, L ^a   Deneva, T ^a   Marinov, B ^a  

^a MEDICAL UNIVERSITY OF PLOVDIV   (Bulgaria)

Author keywords

Apolipoproteins; Asymmetric dimethylarginine; Carotid atherosclerosis; Cell adhesion molecules; Dyslipidemia; Homocysteine; Low density lipoprotein cholesterol; Subclinical atherosclerosis

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN B; BIOLOGICAL MARKER; CELL ADHESION MOLECULE; CHOLESTEROL; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HOMOCYSTEINE; INTERCELLULAR ADHESION MOLECULE 1; LOW DENSITY LIPOPROTEIN CHOLESTEROL; N(G),N(G) DIMETHYLARGININE; PADGEM PROTEIN; TRIACYLGLYCEROL; VASCULAR CELL ADHESION MOLECULE 1; ARGININE; LIPID; N,N-DIMETHYLARGININE;

ADULT; ARTERIAL WALL THICKNESS; ARTICLE; BLOOD LEVEL; BLOOD SAMPLING; BODY MASS; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; COMMON CAROTID ARTERY; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DISEASE MARKER; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FAMILIAL HYPERCHOLESTEROLEMIA; FAMILY HISTORY; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; LINEAR REGRESSION ANALYSIS; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MULTIPLE REGRESSION; PRIORITY JOURNAL; RISK ASSESSMENT; VENOUS BLOOD; WAIST CIRCUMFERENCE; AGE; ANALOGS AND DERIVATIVES; BLOOD; BULGARIA; CAROTID ARTERY; CAROTID ARTERY DISEASES; CASE CONTROL STUDY; COMPLICATION; ECHOGRAPHY; HYPERCHOLESTEROLEMIA; INTIMA; PREDICTIVE VALUE; RISK FACTOR; SEVERITY OF ILLNESS INDEX; STATISTICAL MODEL; TUNICA MEDIA;

ADULT; AGE FACTORS; ARGININE; BIOLOGICAL MARKERS; BULGARIA; CAROTID ARTERIES; CAROTID ARTERY DISEASES; CASE-CONTROL STUDIES; CELL ADHESION MOLECULES; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HOMOCYSTEINE; HUMANS; HYPERCHOLESTEROLEMIA; LINEAR MODELS; LIPIDS; MALE; PREDICTIVE VALUE OF TESTS; RISK ASSESSMENT; RISK FACTORS; SEVERITY OF ILLNESS INDEX; TUNICA INTIMA; TUNICA MEDIA;

EID: 77954111280     PISSN: 14750961     EISSN: 1475097X     Source Type: Journal    
DOI: 10.1111/j.1475-097X.2010.00935.x     Document Type: Article

References (71)

1. Aminbakhsh A, Mancini GBJ. Carotid intima-media thickness measurements: what defines an abnormality? A systematic review. Clin Invest Med 1999, 22:149-157.
2. Angelova E, Minkova G, Tsvetkova T. Total plasma homocysteine in Bulgarian population measured by high-performance liquid chromatography with fluorescent detection - comparison with fluorescence polarization immunoassay. Clin Lab 2006, 52:527-533.
3. Aviv A, Levy D, Mangel M. Growth, telomere dynamics and successful and unsuccessful human aging. Mech Ageing Dev 2003, 124:829-837.
4. Ballantyne CM. Changing lipid-lowering guidelines: whom to treat and how low to go. Eur Heart J 2005, 7(Suppl. A):A12-A19.
5. Ballantyne CM, Bertolami M, Hernandez Garcia HR, Nul D, Stein EA, Theroux P, Weiss R, Cain VA, Raichlen JS. Achieving LDL cholesterol, non-HDL cholesterol, and apolipoprotein B target levels in high-risk patients: measuring effective reductions in cholesterol using rosuvastatin therapy (MERCURY) II. Am Heart J 2006, 151:975-983.
6. Barter PJ, Ballantyne CM, Carmena R, Castro Cabezas M, Chapman MJ, Couture P, de Graaf J, Durrington PN, Faergeman O, Frohlich J, Furberg CD, Gagne C, Haffner SM, Humphries SE, Jungner I, Krauss RM, Kwiterovich P, Marcovina S, Packard CJ, Pearson TA, Reddy KS, Rosenson R, Sarrafzadegan N, Sniderman AD, Stalenhoef AF, Stein E, Talmud PJ, Tonkin AM, Walldius G, Williams KM. Apo B versus cholesterol in estimating cardiovascular risk and in guiding therapy: report of the thirty- person/ten country panel. J Intern Med 2006, 259:247-2458.
7. Benn M, Nordestgaard BG, Jensen GB, Tybjaerg-Hansen A. Improving prediction of ischemic cardiovascular disease in the general population using apolipoprotein B: the Copenhagen City Heart Study. Arterioscler Thromb Vasc Biol 2007, 27:661-670.
8. Bots ML, Baldassarre D, Simon A, de Groot E, O'Leary DH, Riley W, Kastelein JJ, Grobbee DE. Carotid intima-media thickness and coronary atherosclerosis: weak or strong relations? Eur Heart J 2007, 28:398-406.
9. Bots ML, Grobbee DE. Intima media thickness as a surrogate marker for generalised atherosclerosis. Cardiovasc Drugs Ther 2002, 16:341-351.
10. Brunzell JD, Davidson M, Furberg C, Goldberg RB, Howard BV, Stein JH, Witztum JL. Consensus statement from the American Diabetes Association and the American College of Cardiology Foundation. Diabetes Care 2008, 31:811-822.
11. Burke GL, Evans GW, Riley WA, Sharrett AR, Howard G, Barnes RW, Rosamond W, Crow RS, Rautaharju PM, Heiss G. Arterial wall thickness is associated with prevalent cardiovascular disease in middle-aged adults. The Atherosclerosis Risk in Communities (ARIC) Study. Stroke 1995, 26:386-391.
12. Chambless LE, Heiss G, Folsom AR, Rosamond W, Szklo M, Sharrett AR, Clegg LX. Association of coronary heart disease incidence with carotid arterial wall thickness and major risk factors: the Atherosclerosis Risk in Communities (ARIC) Study, 1987-1993. Am J Epidemiol 1997, 146:483-494.
13. Chapman MJ, Laplaud PM, Luc G, Forgez P, Bruckert E, Goulinet S, Lagrange D. Further resolution of the low density lipoprotein spectrum in normal human plasma: physicochemical characteristics of discrete subspecies separated by density gradient ultracentrifugation. J Lipid Res 1988, 29:442-458.
14. Dahlen EM, Lanne T, Engvall J, Lindström T, Grodzinsky E, Nystrom FH, Östgren CJ. Carotid intima-media thickness and apolipoprotein B/apolipoprotein A-I ratio in middle-aged patients with Type 2 diabetes. Diabet Med 2009, 26:384-390.
15. Denke MA. Weighing in before the fight low-density lipoprotein cholesterol and non-high-density lipoprotein cholesterol versus apolipoprotein B as the best predictor for coronary heart disease and the best measure of therapy. Circulation 2005, 112:3368-3370.
16. Durrington PH. Can measurement of apolipoprotein B replace the lipid profile in the follow-up of patients with lipoprotein disorders? Clin Chem 2002, 48:401-402.
17. Elovson J, Chatterton JE, Bell GT, Schumaker VN, Reuben MA, Puppione DL, Reeve JR, Young NL. Plasma very low density lipoproteins contain a single molecule of apolipoprotein B. J Lipid Res 1988, 29:1461-1473.
18. Favre A, Monpere C, Voyer C, Mirguet C, Quilliet-Thebaud N, Vernochet P, Brochier M. How to improve primary prevention in asymptomatic high risk subjects. Eur Heart J 2004, 6(Suppl.):J59-J63.
19. Furuki K, Adachi H, Matsuoka H, Enomoto M, Satoh A, Hino A, Hirai Y, Imaizumi T. Plasma levels of asymmetric dimethylarginine (ADMA) are related to intima-media thickness of the carotid artery: an epidemiological study. Atherosclerosis 2007, 191:206-210.
20. Furuki K, Adachi H, Enomoto M, Otsuka M, Fukami A, Kumagae S, Matsuoka H, Nanjo Y, Kakuma T, Imaizumi T. Plasma level of asymmetric dimethylarginine (ADMA) as a predictor of carotid intima-media thickness progression: six-year prospective study using carotid ultrasonography. Hypertens Res 2008, 31:1185-1189.
21. Ganev VS. Molecular genetic heterogeneity of the predisposition to atherosclerosis in Bulgaria. 2003, 68-70. PhD Thesis, Medical University, Sofia, Bulgarian
22. Gotto AM, Whitney E, Stein EA, Shapiro DR, Clearfield M, Weis S, Jou JY, Langendörfer A, Beere PA, Watson DJ, Downs JR, de Cani JS. Relation between baseline and on-treatment lipid parameters and first acute major coronary events in the AirForce/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS). Circulation 2000, 101:477-484.
23. Graham I, Atar D, Borch-Johnsen K, Boysen G, Burell G, Cifkova R, Dallongeville J, Backer G, Ebrahim S, Gjelsvik B, Herrmann-Lingen C, Arno Hoes A, Humphries S, Knapton M, Perk J, Priori SG, Pyorala K, Reiner Z, Ruilope L, Sans-Menendez S, Reimer W, Weissberg P, Wood D, Yarnell J, Zamorano JL. European guidelines on cardiovascular disease prevention in clinical practice: executive summary: Fourth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (Constituted by representatives of nine societies and by invited experts). Eur Heart J 2007, 28:2375-2414.
24. Grundy SM, Cleeman JI, Merz CN, Brewer HB, Clark LT, Hunninghake DB, Pasternak RC, Smith SC, Stone NJ. Implication of recent clinical trials for the national cholesterol education program adult treatment panel III guidelines. Circulation 2004, 10:227-239.
25. Haluska BA, Fathi R, Jeffriess L, Leano R, Carlier SG, Marwick TH. Noninvasive tests for arterial structure, function, and compliance: do they identify risk or diagnose disease? J Am Soc Echocardiogr 2004, 17:195-204.
26. Hanefeld M, Koehler C, Henkel E, Fuecker K, Schaper F, Temelkova-Kurktschiev T. Post-challenge hyperglycaemia relates more strongly than fasting hyperglycaemia with carotid intima-media thickness: the RIAD Study. Diabet Med 2008, 17(12):835-840.
27. Horvarth AD. Molecular heterogeneity of LDLR and Apo B genes in healthy people and in patients with hypercholesterolemia in Bulgaria. 2001, 68-69. PhD Dissertation, Medical University, Sofia, Bulgarian
28. Horvath A, Chorbov V, Zaharova B, Ganev V. Five polymorphisms of the apolipoprotein B gene in healthy Bulgarians. Hum Biol 2003, 75:69-80.
29. Jadhav UM, Kadam NN. Apolipoproteins: correlation with carotid intimamedia thicknes and coronary artery disease. J Assoc Physicians India 2004, 52:370-375.
30. Junyent M, Cofán M, Núñez I, Gilabert R, Zambón D, Ros E. Influence of HDL cholesterol on preclinical carotid atherosclerosis in familial hypercholesterolemia. Arterioscler Thromb Vasc Biol 2006, 26:1107-1113.
31. Kastelein JJ, van der Steeg WA, Holme I, Gaffney M, Cater NB, Barter P, Deedwania P, Olsson AG, Boekholdt SM, Demicco DA, Szarek M, LaRosa JC, Pedersen TR, Grundy SM. Lipids, apolipoproteins, and their ratios in relation to cardiovascular events with statin treatment. Circulation 2008, 117:3002-3009.
32. Lamarche B, Moorjani S, Lupien PJ, Cantin B, Bernard PM, Dagenais GR, Despres JP. Apolipoprotein A-l and B levels and the risk of ischemic heart disease during a five year follow-up of men in Quebec Cardiovascular Study. Circulation 1996, 94:273-278.
33. Lemieux I, Lamarche B, Couillard C, Pascot A, Cantin B, Bergeron J, Dagenais G, Despres JP. Total cholesterol/HDL-cholesterol ratio vs LDL-cholesterol/HDL-cholesterol ratio as indices od ischemic heart disease risk in man. Arch Intern Med 2001, 161:2685-2692.
34. Lonn E. Carotid artery intimamedia thickness - a new noninvasive gold standard for assessing the anatomic extent of atherosclerosis and cardiovascular risk? Clin Invest Med 1999, 22:158-160.
35. Magyar MT, Paragh G, Katona E, Valikovics A, Seres I, Csiba L, Bereczki D. Serum cholesterols have a more important role than triglycerides in determining intima-media thickness of the common carotid artery in subjects younger than 55 years of age. J Ultrasound Med 2004, 23:1161-1169.
36. Marcovina SM, Albers JJ, Kennedy H, Mei JV, Henderson LO, Hannon WH. International Federation of Clinical Chemistry standardization project for measurements of apolipoproteins A-I and B, IV: comparability of apolipoprotein B values by use of international reference material. Clin Chem 1994, 40:586-592.
37. Martinez LR, Miname MH, Bortolotto LA, Charca AP, Rochitte C, Sposito AC, Santos RD. No correlation and low agreement of imaging and inflammatory atherosclerosis markers in familial hypercholesterolemia. Atherosclerosis 2008, 200:83-88.
38. Meisinger C, Loewel H, Mraz W, Koenig W. Prognostic value of apolipoprotein B and A in the prediction of myocardial infarction in middle-aged men and women: results from MONICA/KORA Augsburg cohort study. Eur Heart J 2005, 26:271-278.
39. Miyazaki H, Matsuoka H, Cooke JP, Usui M, Ueda S, Okuda S, Imaizumi T. Endogenous nitric oxide synthase inhibitor a novel marker of atherosclerosis. Circulation 1999, 99:1141-1146.
40. O'Leary DH, Polak JF, Kronmal RA, Manolio TA, Burke GL, Wolfson SK. Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults: Cardiovascular Health Study Collaborative Research Group. N Engl J Med 1999, 340:14-22.
41. Paiker JE, Raal FJ, Veller M, von Arb M, Chetty N, Naran NH. Cell adhesion molecules - can they be used to predict coronary artery disease in patients with familial hypercholesterolaemia? Clin Chim Acta 2000, 293:105-113.
42. Pignoli P, Tremoli E, Poli A, Oreste P, Paoletti R. Intimal plus medial thickness of the arterial wall: a direct measurement with ultrasound imaging. Circulation 1986, 74:1399-1406.
43. Pischon T, Girman CJ, Sacks FM, Rifai N, Stampfer MJ, Rimm EB. Non- high-density lipoprotein cholesterol and apolipoprotein B in the prediction of coronary heart disease in men. Circulation 2005, 112:3375-3383.
44. Raitakari OT, Juonala M, Kähönen M, Taittonen L, Laitinen T, Mäki-Torkko N, Järvisalo MJ, Uhari M, Jokinen E, Rönnemaa T, Åkerblom HK, Viikari J. Cardiovascular risk factorsin childhood and carotid artery intima-media thickness in adulthood: the Cardiovascular Risk in Young Finns Study. JAMA 2003, 290:2277-2283.
45. Ridker PM, Rifai N, Cook NR, Bradwin G, Buring JE. Non-HDL cholesterol, apolipoproteins A-I and B100, standard lipid measures, lipid ratios, and CRP as risk factors for cardiovascular disease in women. JAMA 2005, 294:326-333.
46. Roeters van Lennep JE, Westerveld HT, Roeters van Lennep H, Zwinderman A, Erkelens D, van der Wall E. Apolipoprotein concentrations during treatment and recurrent coronary artery disease events. Arterioscler Thromb Vasc Biol 2000, 20:2408-2413.
47. Rohde LE, Lee LT, Rivero J, Jamacochian M, Arroyo LH, Briggs W, Rifai N, Libby P, Creager M, Ridker P. Circulating cell adhesion molecules are correlated with ultrasound-based assessment of carotid atherosclerosis. Arterioscler Thromb Vasc Biol 1998, 18:1765-1770.
48. Rosfors S, Hallerstam S, Jensen-Urstad K, Zetterling M, Carlstrom C. Relation between intima-media thickness in the common carotid artery and atherosclerosis in the carotid bifurcation. Stroke 1998, 29:1378-1382.
49. Schmidt C, Wendelhag I. How can the variability in ultrasound measurement of intima-media thickness be reduced? Studies of interobserver variability in carotid and femoral arteries. Clin Physiol 1999, 1:45-55.
50. Schuster H. Under-treated high risk patients: identifying patients in high-risk subgroup and treating them to LDL targets. Eur Heart J 2005, 7(Suppl.):A20-A28.
51. Mortality in treated heterozygous familial hypercholesterolemia: implications for clinical management. Atherosclerosis 1999, 142:105-112.
52. Simes RJ, Marschner IC, Hunt D, Colquhoun D, Sullivan D, Stewart RAH. Relationship between lipid levels and clinical outcomes in the long-term intervention with pravastatin in ischemic disease (LIPID) trial: to what extent is the reduction in coronary events with pravastatin explained by on-study lipid levels? Circulation 2002, 105:1162-1169.
53. Simon A, Gariepy J, Chironi G, Megnien JL, Levenson J. Intima-media thickness: a new tool for diagnosis and treatment of cardiovascular risk. J Hypertens 2002, 20:159-169.
54. Simova I, Denchev S. Endothelial functional and structural impairment in patients with different degrees of coronary artery disease development. Heart Vessels 2008, 23:308-315.
55. Sniderman AD. Apolipoprotein B versus non-high-density lipoprotein cholesterol: and the winner is. Circulation 2005, 112:3366-3367.
56. Sniderman AD, Furberg CD, Keech A, Roeters van Lennep JE, Frohlich J, Jungner I, Walldius G. Apolipoproteins versus lipids as indices of coronary risk and as targets for statin treatment. Lancet 2003, 361:777-780.
57. St-Pierre AC, Can tin B, Dagenais GR, Despres JP, Lamarche B. Apolipoprotein-B, low-density lipoprotein cholesterol, and the long-term risk of coronary heart disease in men. Am J Cardiol 2006, 97:997-1001.
58. Sweetnam PM, Bolton CH, Downs LG, Durrington PN, Mackness MI, Elwood PC, Yarnell JWG. Apolipoproteins A-I, A-II and B, lipoprotein(a) and the risk of ischaemic heart disease: the Caerphilly Study. Eur J Clin Invest 2000, 30:947-956.
59. Tegos TG, Kalomiris KG, Sabetai MM, Kalodiki E, Nicolaides AN. Significance of Sonographic Tissue and Surface Characteristics of Carotid Plagues. American Journal of Neuroradiology 2001, 22:1605-1612.
60. Temelkova-Kurktschiev T, Koehler C, Schaper F, Henkel E, Hahnefeld A, Fuecker K, Siegert G, Hanefeld M. Relationship between fasting plasma glucose, atherosclerosis risk factors and carotid intima media thickness in non-diabetic individuals. Diabetologia 1998, 41:706-712.
61. Temelkova-Kurktschiev T, Koehler C, Henkel E, Hanefeld M. Leukocyte count and fibrinogen are associated with carotid and femoral intima-media thickness in a risk population for diabetes. Cardiovasc Res 2002, 56:277-283.
62. Thompson A, Danesh J. Associations between apolipoprotein B, apolipoprotein AI, the apolipoprotein B/AI ratio and coronary heart disease: a literature-based meta-analysis of prospective studies. J Intern Med 2006, 259:481-492.
63. Tsivgoulis G, Vemmos K, Papamichael C, Spengos K, Manios E, Stamatelopoulos K, Vassilopoulos D, Zakopoulos N. Recurrence common carotid artery intima-media thickness and the risk of stroke. Stroke 2006, 37:1913-1916.
64. Van der Steeg WA, Boekholdt SM, Stein EA, El-Harchaoui K, Stroes ES, Sandhu MS, Wareham NJ, Jukema JW, Luben R, Zwinderman AH. Role of the apolipoprotein B-apolipoprotein A ratio in cardiovascular risk assessments: case-control analysis in EPIC-Norfolk. Ann Intern Med 2007, 146:640-648.
65. Vaverkova H, Karasek D, Novotny D, Jackuliakova D, Lukes J, Halenka M, Frohlich J. Apolipoprotein B versus LDL-cholesterol: association with other risk factors for atherosclerosis. Clin Biochem 2009, 42:1246-1251.
66. Vaverková H, Soska V, Rosolová H, Ceska R, Cífková R, Freiberger T, Pit'ha J, Poledne R, Stulc T, Urbanová Z, Vráblík M. Czech Atherosclerosis Society Guidelines for the Diagnosis and Treatment of Dyslipidemias in Adults (Doporuceni pro diagnostiku a lecbu dyslipidemii v dospelosti, vypracovane vyborem Cesle spolecnosti pro aterosklerozu). VnitfniLek 2007, 53:181-197.
67. Vladimirova-Kitova L, Deneva T, Nikolov F, Dgurdgev A. Carotid atherosclerosis in familial defect Apo-B and familial hypercholesterolemia. Cor Lung 2003, 4:39-46.
68. Vladimirova-Kitova LG, Deneva T, Angelova E, Bichev AN, Nikolov F. Role of some biomarkers of atherosclerosis in the screening for molecular defects in the low density lipoprotein receptor in severe hypercholesterolemia. Folia Med 2008a, 50:14-22.
69. Vladimirova-Kitova LG, Deneva T, Angelova E, Nikolov F, Marinov B, Mateva N. Relationship of asymmetric dimethylarginine with flow-mediated dilation in subjects with newly detected severe hypercholesterolemia. Clin Physiol Funct Imaging 2008b, 28:417-425.
70. Walldius G, Jungner I. Apo lipoprotein B and apolipoprotein A-I: risk indicators of coronary heart disease and targets for lipid-modifying therapy. J Intern Med 2004, 255:188-205.
71. Zoccali C, Bode-Boger S, Mallamaci F, Benedetto F, Tripepi G, Malantino L, Cataliotti A, Bellanuova I, Fermo I, Frolich J, Boger R. Plasma concentration of asymmetrical dimethylarginine and mortality in patients with end-stage renal disease: a prospective study. Lancet 2001, 358:2113-2117.